Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"
BCL11B	"CTIP-2, CTIP2, hRIT1-alpha, ZNF856B"	ENSG00000127152	"BAF chromatin remodeling complex subunit BCL11B"	Q9C0K0	14	99169287-99272197	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Intellectual disability, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.2;lymphoid tissue: 36.6;skin 1: 15.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 84.8;Basal squamous epithelial cells: 90.5;Inhibitory neurons: 103.1;NK-cells: 137.8;Suprabasal keratinocytes: 77.0;T-cells: 295.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 8.0;basal ganglia: 21.2;cerebral cortex: 17.2;hippocampal formation: 18.9"	"Group enriched"	"Detected in many"	8	"gdT-cell: 2.0;MAIT T-cell: 1.8;memory CD4 T-cell: 2.8;memory CD8 T-cell: 2.4;naive CD4 T-cell: 4.6;naive CD8 T-cell: 3.1;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	14	"T-cells: 4.6"	"Group enriched"	"Detected in some"	6	"Bone cancer: 18.1;Leukemia: 6.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - Keratinocyte (other), Testis - Spermatogonia, Thyroid - T-cells"	"Region enhanced"	"Detected in many"		"basal ganglia: 64.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 30.0"	HPA049117	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 14: Bone cancer - Transcription"	"Cluster 1: T-cells - Immune response"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA049117: AB_2680639"	"unprognostic (1.64e-5)"	"unprognostic (4.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.60e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.31e-3)"	"prognostic favorable (7.48e-4)"
CD247	"CD3H, CD3Q, CD3Z"	ENSG00000198821	"CD247 molecule"	P20963	1	167430640-167518610	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"bone marrow: 49.0;lymphoid tissue: 179.4"	"Group enriched"	"Detected in many"	22	"NK-cells: 788.2;T-cells: 243.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	25	"gdT-cell: 376.4;MAIT T-cell: 208.9;memory CD4 T-cell: 190.0;memory CD8 T-cell: 219.7;naive CD4 T-cell: 237.8;naive CD8 T-cell: 195.1;NK-cell: 225.3;T-reg: 254.5"	"Group enriched"	"Detected in all"	32	"NK-cells: 225.3;T-cells: 376.4"	"Group enriched"	"Detected in some"	24	"Leukemia: 23.3;lymphoma: 24.2;Myeloma: 17.4"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004651, HPA008750"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"			"CAB004651: AB_425347, HPA008750: AB_1857863"	"prognostic favorable (9.12e-4)"	"unprognostic (3.21e-3)"	"unprognostic (7.09e-3)"	"prognostic favorable (8.63e-6)"	"unprognostic (1.99e-2)"	"prognostic favorable (3.98e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.46e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (9.94e-6)"	"unprognostic (1.60e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.94e-3)"
CD3G		ENSG00000160654	"CD3g molecule"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 94.7"	"Group enriched"	"Detected in many"	4	"NK-cells: 96.8;T-cells: 326.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	21	"gdT-cell: 229.0;MAIT T-cell: 135.6;memory CD4 T-cell: 187.3;memory CD8 T-cell: 197.3;naive CD4 T-cell: 192.6;naive CD8 T-cell: 241.7;T-reg: 200.0"	"Lineage enriched"	"Detected in many"	26	"T-cells: 241.7"	"Cancer enriched"	"Detected in some"	7	"Leukemia: 19.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Stomach - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB017520: AB_831094, HPA038494: AB_2676044"	"prognostic favorable (6.33e-4)"	"prognostic favorable (2.61e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.12e-5)"	"unprognostic (6.30e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (9.33e-5)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.10e-3)"
CD7	"GP40, LEU-9, Tp40, TP41"	ENSG00000173762	"CD7 molecule"	P09564	17	82314868-82317608	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.6;lymphoid tissue: 53.7"	"Group enriched"	"Detected in many"	14	"NK-cells: 1172.5;T-cells: 544.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 231.5"	"Group enriched"	"Detected in many"	22	"NK-cells: 231.5;T-cells: 71.5"	"Group enriched"	"Detected in some"	7	"Leukemia: 49.8;liver cancer: 16.2;Myeloma: 24.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Heart muscle - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Region enhanced"	"Detected in some"		"cerebral cortex: 3.2"	"Not detected"	"Not detected"			"CAB002594, HPA039079"	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"			"CAB002594: , HPA039079: AB_2676337"	"unprognostic (3.14e-3)"	"prognostic favorable (5.51e-4)"	"unprognostic (1.89e-2)"	"prognostic favorable (2.03e-5)"	"unprognostic (7.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.69e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (7.75e-11)"	"unprognostic (4.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.55e-3)"
CD8A	CD8	ENSG00000153563	"CD8a molecule"	P01732	2	86784610-86808396	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"lymphoid tissue: 369.0"	"Cell type enriched"	"Detected in many"	4	"T-cells: 231.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"MAIT T-cell: 234.4;memory CD8 T-cell: 523.0;naive CD8 T-cell: 476.8"	"Lineage enriched"	"Detected in many"	19	"T-cells: 523.0"	"Group enriched"	"Detected in some"	8	"Leukemia: 6.0;lymphoma: 10.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Stomach - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000012, HPA037756, CAB075722"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		490000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane"		"CAB000012: AB_2075537, CAB075722: AB_2665709, HPA037756: AB_2675648"	"unprognostic (1.29e-3)"	"prognostic favorable (4.54e-4)"	"unprognostic (9.26e-3)"	"prognostic favorable (6.15e-6)"	"unprognostic (7.28e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.56e-2)"
CD8B	CD8B1	ENSG00000172116	"CD8b molecule"	P10966	2	86815339-86861924	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"lymphoid tissue: 459.6"	"Cell type enriched"	"Detected in many"	6	"T-cells: 154.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"memory CD8 T-cell: 601.8;naive CD8 T-cell: 1053.9"	"Lineage enriched"	"Detected in all"	25	"T-cells: 1053.9"	"Group enriched"	"Detected in some"	8	"Leukemia: 8.8;Myeloma: 33.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Stomach - T-cells, Thyroid - T-cells"									"CAB004353, HPA029164"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane"		"CAB004353: AB_627211, HPA029164: AB_2672936"	"unprognostic (1.83e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-2)"	"prognostic favorable (7.88e-7)"	"unprognostic (6.23e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.50e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.60e-1)"	"prognostic unfavorable (7.11e-6)"	"unprognostic (7.84e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.33e-2)"
CD96	TACTILE	ENSG00000153283	"CD96 molecule"	P40200	3	111292719-111665750	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 61.8"	"Group enriched"	"Detected in many"	6	"NK-cells: 121.7;T-cells: 195.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdT-cell: 74.0;MAIT T-cell: 117.2;memory CD4 T-cell: 67.0;memory CD8 T-cell: 85.3;naive CD4 T-cell: 68.7;naive CD8 T-cell: 81.8;NK-cell: 79.5;T-reg: 47.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 79.5;T-cells: 117.2"	"Cancer enhanced"	"Detected in many"		"Leukemia: 31.4;skin cancer: 16.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA066754	Enhanced					NA	NA		85000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"			"HPA066754: AB_2685714"	"unprognostic (1.06e-3)"	"unprognostic (3.95e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.91e-5)"	"unprognostic (4.72e-3)"	"prognostic favorable (5.52e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.48e-2)"	"unprognostic (6.06e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (2.02e-6)"	"unprognostic (3.12e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.90e-2)"	"prognostic favorable (5.23e-5)"
CXCR3	"CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR"	ENSG00000186810	"C-X-C motif chemokine receptor 3"	P49682	X	71615916-71618511	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.2;intestine: 6.4;lymphoid tissue: 16.3"	"Cell type enriched"	"Detected in some"	8	"dendritic cells: 385.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 306.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 306.7;NK-cells: 198.9;T-cells: 124.7"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 1.6;Leukemia: 1.5;lymphoma: 5.9;Myeloma: 4.3"	"Adipose subcutaneous - T-cells, Colon - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045942	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 16: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 48: Plasmacytoid dendritic cells - Unknown function"			"HPA045942: AB_2679507"	"unprognostic (4.84e-3)"	"unprognostic (3.05e-3)"	"unprognostic (1.61e-1)"	"prognostic favorable (3.44e-6)"	"unprognostic (3.93e-2)"	"prognostic favorable (3.35e-4)"	"unprognostic (1.01e-2)"	"unprognostic (5.24e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.67e-6)"	"unprognostic (4.67e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.76e-2)"
CXCR6	"BONZO, CD186, STRL33, TYMSTR"	ENSG00000172215	"C-X-C motif chemokine receptor 6"	O00574	3	45940933-45948351	"CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.0"	"Group enriched"	"Detected in some"	7	"Extravillous trophoblasts: 88.1;T-cells: 57.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 445.8"	"Lineage enriched"	"Detected in many"	5	"T-cells: 445.8"	"Cancer enhanced"	"Detected in some"		"Gallbladder cancer: 2.0"	"Kidney - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 1: T-cells - Immune response"				"unprognostic (2.05e-3)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.77e-3)"	"prognostic favorable (6.74e-6)"	"unprognostic (6.67e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.65e-4)"	"unprognostic (8.57e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (2.25e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.57e-2)"
GBP5		ENSG00000154451	"Guanylate binding protein 5"	Q96PP8	1	89258950-89272804	"Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Antimicrobial, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.9;lymphoid tissue: 73.9"	"Group enriched"	"Detected in many"	4	"monocytes: 38.2;NK-cells: 74.0;T-cells: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"T-reg: 243.8"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 11.7;lymphoma: 11.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Testis - Spermatogonia, Thyroid - T-cells"	"Low region specificity"	"Detected in many"							HPA028656	Supported					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"			"HPA028656: AB_10601471"	"unprognostic (2.72e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.54e-4)"	"prognostic favorable (3.73e-6)"	"unprognostic (8.33e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.71e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.24e-4)"	"unprognostic (3.47e-2)"	"unprognostic (4.16e-1)"	"prognostic unfavorable (5.53e-8)"	"unprognostic (2.75e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.11e-2)"
GPR174	FKSG79	ENSG00000147138	"G protein-coupled receptor 174"	Q9BXC1	X	79144688-79175318	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 16.9"	"Group enriched"	"Detected in some"	4	"B-cells: 34.3;NK-cells: 37.3;T-cells: 75.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Leukemia: 10.7;lymphoma: 3.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Pancreas - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041025, HPA058306"	Enhanced		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"	"Plasma membrane"	"Vesicles, Centriolar satellite"	"HPA041025: AB_10794260, HPA058306: "	"unprognostic (6.38e-3)"	"unprognostic (9.87e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.48e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.53e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-2)"
GRAP2	"GADS, GRBLG, GrbX, Grf40, Mona"	ENSG00000100351	"GRB2 related adaptor protein 2"	O75791	22	39901084-39973721	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"lymphoid tissue: 184.8"	"Group enriched"	"Detected in many"	7	"Erythroid cells: 28.7;granulocytes: 107.3;NK-cells: 43.6;T-cells: 56.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"gdT-cell: 51.4;MAIT T-cell: 38.2;memory CD4 T-cell: 37.5;memory CD8 T-cell: 56.2;naive CD4 T-cell: 31.3;naive CD8 T-cell: 58.2;T-reg: 35.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 58.2"	"Cancer enriched"	"Detected in some"	6	"Leukemia: 27.7"	"Adipose visceral - T-cells, Kidney - T-cells, Pancreas - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005788, CAB022073"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		290000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 4: Platelets - Platelet activation"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022073: , HPA005788: AB_1079021"	"unprognostic (1.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (4.19e-2)"	"unprognostic (8.91e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.56e-5)"	"unprognostic (1.27e-2)"	"unprognostic (8.41e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.06e-2)"
GZMM	"LMET1, MET1"	ENSG00000197540	"Granzyme M"	P51124	19	544034-549924	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.6;lymphoid tissue: 22.7"	"Group enriched"	"Detected in many"	41	"NK-cells: 678.2;T-cells: 222.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 583.9"	"Group enriched"	"Detected in all"	33	"NK-cells: 194.9;T-cells: 583.9"	"Cancer enhanced"	"Detected in some"		"Leukemia: 5.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015624	Enhanced				"Secreted to blood"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"			"HPA015624: AB_2669245"	"unprognostic (2.97e-3)"	"unprognostic (2.29e-3)"	"unprognostic (7.53e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.87e-7)"	"unprognostic (2.35e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.94e-2)"
IL2RG	"CD132, CIDX, IMD4, SCIDX1"	ENSG00000147168	"Interleukin 2 receptor subunit gamma"	P31785	X	71107404-71112108	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 118.0;lymphoid tissue: 346.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 112.9;dendritic cells: 93.7;Distal enterocytes: 87.2;Langerhans cells: 151.6;NK-cells: 284.8;Plasma cells: 91.0;Proximal enterocytes: 80.8;T-cells: 197.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Leukemia: 203.1;lymphoma: 129.5;Myeloma: 347.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"									HPA046641	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane"		NA	NA		13000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Nucleoplasm, Plasma membrane"	"Endoplasmic reticulum"	"HPA046641: AB_2679733"	"unprognostic (2.97e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (8.25e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.28e-7)"	"unprognostic (1.73e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.54e-2)"
ITGAL	"CD11A, LFA-1"	ENSG00000005844	"Integrin subunit alpha L"	P20701	16	30472658-30523567	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction, Phagocytosis"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.8;lymphoid tissue: 64.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 43.6;monocytes: 151.0;NK-cells: 195.1;T-cells: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 121.7"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	125	"Leukemia: 74.5;lymphoma: 40.6;Myeloma: 51.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025011	Enhanced					NA	NA		1600000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 62: Granulocytes - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"			"CAB025011: "	"unprognostic (1.10e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.72e-3)"	"prognostic favorable (5.63e-5)"	"unprognostic (2.88e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (5.69e-3)"	"prognostic favorable (5.57e-4)"	"unprognostic (3.37e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-2)"
KLRB1	"CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A"	ENSG00000111796	"Killer cell lectin like receptor B1"	Q12918	12	9594551-9607916	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.4;lymphoid tissue: 36.4"	"Group enriched"	"Detected in many"	7	"NK-cells: 1508.8;T-cells: 767.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in all"		"MAIT T-cell: 2177.1"	"Group enriched"	"Detected in all"	140	"NK-cells: 756.7;T-cells: 2177.1"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"					"Not detected"	"Not detected"			HPA039113	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"	Nucleoplasm	Cytosol	"HPA039113: AB_10674979"	"prognostic favorable (3.51e-5)"	"unprognostic (1.23e-3)"	"unprognostic (7.03e-3)"	"prognostic favorable (1.42e-5)"	"unprognostic (1.69e-1)"	"prognostic favorable (6.99e-5)"	"unprognostic (1.54e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.12e-1)"	"unprognostic (8.23e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (1.17e-2)"
KLRC1	"CD159a, NKG2, NKG2-A, NKG2-B"	ENSG00000134545	"Killer cell lectin like receptor C1"	P26715	12	10442264-10454685	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 6.7"	"Group enriched"	"Detected in some"	5	"NK-cells: 229.4;T-cells: 105.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 229.2;NK-cell: 367.6"	"Group enriched"	"Detected in many"	46	"NK-cells: 367.6;T-cells: 229.2"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Liver - NK-cells (Liver), Pancreas - T-cells, Prostate - T-cells"									HPA058052			Approved	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane"		"HPA058052: AB_2683589"	"unprognostic (8.17e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.58e-7)"	"unprognostic (3.57e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.73e-4)"	"unprognostic (4.13e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.88e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.92e-3)"
KLRC4	NKG2-F	ENSG00000183542	"Killer cell lectin like receptor C4"	O43908	12	10407382-10409757	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 9.4"	"Group enriched"	"Detected in some"	7	"NK-cells: 25.4;T-cells: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	20	"gdT-cell: 8.2;memory CD8 T-cell: 5.9;naive CD8 T-cell: 6.7;NK-cell: 4.7"	"Group enriched"	"Detected in many"	59	"NK-cells: 4.7;T-cells: 8.2"	"Cancer enhanced"	"Detected in some"		"lymphoma: 8.0"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Pancreas - T-cells, Prostate - T-cells, Stomach - T-cells, Testis - Early spermatids, Thyroid - T-cells"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (3.96e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.60e-1)"		"unprognostic (7.00e-2)"	"unprognostic (1.55e-4)"		"unprognostic (1.89e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.36e-1)"	"unprognostic (3.44e-7)"	"unprognostic (1.49e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.68e-1)"	"unprognostic (5.51e-3)"
KLRK1	"CD314, D12S2489E, KLR, NKG2-D, NKG2D"	ENSG00000213809	"Killer cell lectin like receptor K1"	P26718	12	10372353-10391874	"Cancer-related genes, CD markers, Predicted membrane proteins, Transporters"	"Adaptive immunity, Differentiation, Immunity, Innate immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.1;lymphoid tissue: 42.9"	"Group enriched"	"Detected in some"	5	"NK-cells: 26.5;T-cells: 41.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	40	"gdT-cell: 287.4;MAIT T-cell: 111.5;memory CD8 T-cell: 261.2;naive CD8 T-cell: 258.8;NK-cell: 335.8"	"Group enriched"	"Detected in all"	50	"NK-cells: 335.8;T-cells: 287.4"	"Group enriched"	"Detected in some"	11	"Leukemia: 10.3;lymphoma: 33.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB021896, HPA068877"	Enhanced		Supported	"Plasma membrane"		NA	NA		47000	"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"	"Plasma membrane"		"CAB021896: , HPA068877: AB_2686052"	"unprognostic (3.34e-4)"	"unprognostic (2.65e-4)"	"unprognostic (3.25e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-5)"	"unprognostic (5.61e-4)"	"unprognostic (1.00e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-10)"	"unprognostic (1.24e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.59e-2)"	"unprognostic (7.08e-10)"
LY9	"CD229, hly9, mLY9, SLAMF3"	ENSG00000122224	"Lymphocyte antigen 9"	Q9HBG7	1	160796074-160828261	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.5;intestine: 12.0;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 245.9;dendritic cells: 62.8;Langerhans cells: 37.8;Plasma cells: 72.1;T-cells: 45.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 112.9;MAIT T-cell: 113.5;memory B-cell: 56.1;memory CD4 T-cell: 97.6;memory CD8 T-cell: 109.8;naive B-cell: 52.8;naive CD4 T-cell: 109.6;naive CD8 T-cell: 112.3;plasmacytoid DC: 72.8;T-reg: 80.3"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"lymphoma: 12.3;Myeloma: 38.9"	"Adipose visceral - T-cells, Colon - T-cells, Heart muscle - T-cells, Liver - T-cells, Pancreas - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050917	Approved		Approved	"Plasma membrane,Centriolar satellite"		NA	NA		43000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	"Plasma membrane"	"Centriolar satellite"	"HPA050917: AB_2681272"	"unprognostic (8.04e-4)"	"unprognostic (2.31e-5)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.87e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.69e-2)"	"unprognostic (9.47e-2)"	"unprognostic (3.49e-2)"	"unprognostic (6.88e-2)"
MAP4K1	HPK1	ENSG00000104814	"Mitogen-activated protein kinase kinase kinase kinase 1"	Q92918	19	38587641-38618882	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 30.1;lymphoid tissue: 56.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 43.5;dendritic cells: 52.8;Langerhans cells: 30.6;monocytes: 22.5;Plasma cells: 34.7;Rod photoreceptor cells: 65.2;T-cells: 39.5"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.2"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	39	"Leukemia: 16.9;lymphoma: 52.8;Myeloma: 29.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA007419, CAB007754"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 44: Photoreceptor cells - Visual perception"	"Plasma membrane"		"CAB007754: AB_562299, HPA007419: AB_1853778"	"unprognostic (1.99e-3)"	"prognostic favorable (6.17e-5)"	"unprognostic (9.50e-3)"	"unprognostic (3.27e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (4.88e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (7.99e-10)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.50e-2)"
PRF1	"HPLH2, P1, PFP"	ENSG00000180644	"Perforin 1"	P14222	10	70597348-70602759	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Cytolysis		"Cancer-related genes, Disease variant, Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 28.6;lung: 16.5;lymphoid tissue: 49.4"	"Cell type enriched"	"Detected in some"	4	"NK-cells: 1120.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 900.4;MAIT T-cell: 628.8;memory CD8 T-cell: 499.1;naive CD8 T-cell: 313.0;NK-cell: 656.8"	"Group enriched"	"Detected in all"	50	"NK-cells: 656.8;T-cells: 900.4"	"Cancer enriched"	"Detected in some"	7	"lymphoma: 61.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Lung - NK-cells (Lung), Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002436, HPA037940"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"	Cytosol		"CAB002436: AB_563955, HPA037940: AB_2675747"	"unprognostic (6.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (6.98e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.69e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.97e-3)"	"unprognostic (5.22e-3)"
SEPTIN1	"DIFF6, PNUTL3, SEPT1"	ENSG00000180096	"Septin 1"	Q8WYJ6	16	30378133-30395991	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 16.7;lymphoid tissue: 35.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 98.3;NK-cells: 87.5;T-cells: 155.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	58	"Leukemia: 27.5;lymphoma: 32.6;Myeloma: 19.8"	"Adipose visceral - T-cells, Breast - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA041566, HPA060339, HPA073635"	Enhanced		Approved	"Actin filaments"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"	"Actin filaments"		"HPA041566: AB_10794671, HPA060339: , HPA073635: "	"unprognostic (3.65e-3)"	"prognostic favorable (9.72e-5)"	"unprognostic (5.06e-2)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.32e-4)"	"prognostic favorable (6.63e-4)"	"unprognostic (2.08e-1)"	"prognostic favorable (7.24e-5)"	"unprognostic (1.24e-2)"	"unprognostic (6.52e-3)"	"prognostic favorable (2.22e-4)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (2.40e-7)"	"unprognostic (1.48e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.72e-2)"
SIRPG	"bA77C3.1, CD172g, SIRP-B2, SIRPB2, SIRPgamma"	ENSG00000089012	"Signal regulatory protein gamma"	Q9P1W8	20	1629152-1657779	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 39.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 63.4;T-cells: 39.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 369.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 369.4"	"Cancer enhanced"	"Detected in some"		"Leukemia: 2.3;ovarian cancer: 2.2;thyroid cancer: 4.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Stomach - T-cells, Testis - Early spermatids, Testis - Late spermatids"															NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (3.35e-3)"	"unprognostic (4.09e-3)"	"unprognostic (7.32e-3)"	"prognostic favorable (1.05e-6)"	"unprognostic (4.23e-3)"	"prognostic favorable (2.24e-4)"	"unprognostic (4.49e-2)"	"unprognostic (1.30e-2)"	"prognostic favorable (7.36e-7)"	"unprognostic (1.62e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (1.47e-6)"	"unprognostic (1.03e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.95e-3)"
TBX21	"T-bet, TBLYM"	ENSG00000073861	"T-box transcription factor 21"	Q9UL17	17	47733236-47746122	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Asthma, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 11.1;lung: 3.3;lymphoid tissue: 11.7"	"Group enriched"	"Detected in some"	10	"NK-cells: 128.0;T-cells: 42.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 15.7;NK-cell: 14.3"	"Group enriched"	"Detected in many"	7	"NK-cells: 14.3;T-cells: 15.7"	"Group enriched"	"Detected in some"	13	"Leukemia: 1.8;lymphoma: 4.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Testis - Spermatogonia, Thyroid - T-cells"	"Region enriched"	"Detected in single"	27	"olfactory bulb: 22.1"	"Region enriched"	"Detected in single"	4	"olfactory bulb: 4.2"	"CAB009524, CAB030043"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 7: NK-cells - Immune response regulation"			"CAB009524: AB_2200557, CAB030043: AB_1595503"	"unprognostic (3.31e-3)"	"unprognostic (3.17e-3)"	"unprognostic (1.17e-2)"	"unprognostic (5.35e-6)"	"unprognostic (3.93e-1)"	"unprognostic (2.56e-4)"	"unprognostic (5.86e-4)"	"unprognostic (6.90e-2)"	"unprognostic (3.63e-3)"	"unprognostic (6.26e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.04e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.19e-3)"	"unprognostic (4.43e-3)"
THEMIS	"bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA"	ENSG00000172673	"Thymocyte selection associated"	Q8N1K5	6	127708072-127918631	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 32.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 46.3;Microglial cells: 14.6;Serous glandular cells: 10.9;T-cells: 66.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	22	"gdT-cell: 26.7;MAIT T-cell: 34.0;memory CD4 T-cell: 33.5;memory CD8 T-cell: 48.9;naive CD4 T-cell: 30.0;naive CD8 T-cell: 58.3"	"Lineage enriched"	"Detected in single"	88	"T-cells: 58.3"	"Group enriched"	"Detected in some"	19	"Leukemia: 3.6;lymphoma: 3.1;Myeloma: 5.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Stomach - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031422, HPA031425"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	Cytosol	Nucleoplasm	"HPA031422: AB_2673874, HPA031425: AB_10670129"	"unprognostic (1.47e-4)"	"unprognostic (2.50e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.41e-1)"	"unprognostic (5.20e-3)"	"unprognostic (7.48e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.65e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-2)"
TRBC1	"BV05S1J2.2, TCRBC1"	ENSG00000211751	"T cell receptor beta constant 1"		7	142791694-142793368	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	28	"lymphoid tissue: 1520.1"	"Group enriched"	"Detected in many"	17	"NK-cells: 443.4;T-cells: 435.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 3232.4"	"Lineage enriched"	"Detected in all"	9	"T-cells: 3232.4"	"Cancer enriched"	"Detected in some"	6	"Leukemia: 98.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (1.08e-4)"	"unprognostic (7.96e-4)"	"unprognostic (6.02e-2)"	"unprognostic (1.26e-4)"	"unprognostic (1.81e-2)"	"unprognostic (5.42e-5)"	"unprognostic (1.76e-2)"	"unprognostic (6.94e-3)"	"unprognostic (2.36e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.18e-6)"	"unprognostic (3.98e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.19e-3)"
TRBC2	TCRBC2	ENSG00000211772	"T cell receptor beta constant 2"		7	142801041-142802748	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	5	"intestine: 115.8;lymphoid tissue: 190.2"	"Group enriched"	"Detected in many"	4	"B-cells: 150.2;NK-cells: 264.0;T-cells: 515.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"T-reg: 76.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 76.0"	"Cancer enriched"	"Detected in single"	15	"Leukemia: 12.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"				"prognostic favorable (8.04e-5)"	"prognostic favorable (1.80e-4)"	"unprognostic (4.19e-3)"	"prognostic favorable (3.42e-8)"	"unprognostic (5.53e-2)"	"prognostic favorable (6.58e-5)"	"unprognostic (3.21e-2)"	"unprognostic (1.30e-2)"	"prognostic favorable (2.81e-4)"	"unprognostic (7.53e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (2.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.09e-3)"
TRGC2	"TCRGC2, TRGC2(2X), TRGC2(3X)"	ENSG00000227191	"T cell receptor gamma constant 2"		7	38239580-38249572	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"bone marrow: 30.5;lymphoid tissue: 34.6;prostate: 23.7"	"Group enriched"	"Detected in some"	4	"NK-cells: 84.0;T-cells: 110.9"	"Cancer enriched"	"Detected in many"	18	"prostate cancer: 26.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 720.5"	"Lineage enriched"	"Detected in many"	5	"T-cells: 720.5"	"Group enriched"	"Detected in some"	23	"Leukemia: 42.6;prostate cancer: 13.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Pancreas - T-cells, Prostate - Prostate glandular cells, Skin - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (2.79e-3)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.62e-4)"	"unprognostic (3.52e-5)"	"unprognostic (3.34e-1)"	"unprognostic (1.46e-3)"	"unprognostic (8.79e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-3)"
UBASH3A	"CLIP4, STS-2, TULA"	ENSG00000160185	"Ubiquitin associated and SH3 domain containing A"	P57075	21	42403447-42447684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 18.9"	"Cell type enriched"	"Detected in some"	5	"T-cells: 21.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"gdT-cell: 12.9;MAIT T-cell: 22.9;memory CD4 T-cell: 28.2;memory CD8 T-cell: 24.8;naive CD4 T-cell: 32.2;naive CD8 T-cell: 24.0;T-reg: 27.9"	"Lineage enriched"	"Detected in many"	12	"T-cells: 32.2"	"Group enriched"	"Detected in some"	57	"Leukemia: 8.9;lymphoma: 2.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA035367			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"	Nucleoplasm	"Golgi apparatus"	"HPA035367: AB_2732466"	"unprognostic (5.14e-4)"	"unprognostic (3.91e-4)"	"unprognostic (1.57e-2)"	"unprognostic (4.10e-5)"	"unprognostic (4.33e-2)"	"unprognostic (1.85e-6)"	"unprognostic (5.54e-4)"	"unprognostic (1.46e-3)"	"unprognostic (6.17e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.37e-6)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"
ZNF683	"Hobit, MGC33414"	ENSG00000176083	"Zinc finger protein 683"	Q8IZ20	1	26361634-26374522	"Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 81.9"	"Group enriched"	"Detected in some"	14	"Early spermatids: 346.9;Late spermatids: 550.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 172.4;memory CD8 T-cell: 113.1"	"Lineage enriched"	"Detected in many"	15	"T-cells: 172.4"	"Cancer enriched"	"Detected in single"	5	"Leukemia: 2.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Pancreas - T-cells, Testis - Late spermatids, Thyroid - T-cells"					"Not detected"	"Not detected"			HPA023865	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 24: Spermatids - Unknown function"			"HPA023865: AB_2671333"	"unprognostic (3.95e-3)"	"unprognostic (5.58e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (2.90e-5)"	"unprognostic (9.17e-2)"	"unprognostic (8.98e-4)"	"unprognostic (7.90e-2)"	"unprognostic (5.05e-3)"	"unprognostic (5.81e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.54e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (3.45e-5)"